CHM chimeric therapeutics limited

Ann: Entitlement Offer closing date extended to 30 November 2023, page-10

  1. 14,233 Posts.
    lightbulb Created with Sketch. 4253
    That's the problem here: He brought money and brilliant technologies / scientists together and it was easy to raise $$$ for the IPOs when the sun was shining. Unfortunately it seems he is not able to continue the run when it's raining. That's when the true quality of a leader has to come through. Yes, he is still able to raise funds but is not able or willing to achieve at a price that's adequate. The data have been brilliant but he hasn't even tried to "sell" them to the market for the CR / SPP / RIs.

    Once known to be a "Mr Huge Discount" it is hard to come back to demand higher valuations later on.

    That's the concern I raised at IMU, RAD and here.

    GLTA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $6.045M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $22.28K 6.311M

Buyers (Bids)

No. Vol. Price($)
78 84735861 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 86304338 23
View Market Depth
Last trade - 14.27pm 25/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.